JP2017526695A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017526695A5 JP2017526695A5 JP2017512679A JP2017512679A JP2017526695A5 JP 2017526695 A5 JP2017526695 A5 JP 2017526695A5 JP 2017512679 A JP2017512679 A JP 2017512679A JP 2017512679 A JP2017512679 A JP 2017512679A JP 2017526695 A5 JP2017526695 A5 JP 2017526695A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- patient
- composition according
- anamorelin
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2018113592A JP6923486B2 (ja) | 2014-09-04 | 2018-06-14 | アナモレリンに基づく医療 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462045976P | 2014-09-04 | 2014-09-04 | |
| US62/045,976 | 2014-09-04 | ||
| PCT/US2015/047435 WO2016036598A1 (en) | 2014-09-04 | 2015-08-28 | Medical treatments based on anamorelin |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018113592A Division JP6923486B2 (ja) | 2014-09-04 | 2018-06-14 | アナモレリンに基づく医療 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017526695A JP2017526695A (ja) | 2017-09-14 |
| JP2017526695A5 true JP2017526695A5 (cg-RX-API-DMAC7.html) | 2017-10-26 |
| JP6356907B2 JP6356907B2 (ja) | 2018-07-11 |
Family
ID=55436476
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017512679A Active JP6356907B2 (ja) | 2014-09-04 | 2015-08-28 | アナモレリンに基づく医療 |
| JP2018113592A Active JP6923486B2 (ja) | 2014-09-04 | 2018-06-14 | アナモレリンに基づく医療 |
| JP2021029775A Active JP7044918B2 (ja) | 2014-09-04 | 2021-02-26 | アナモレリンに基づく医療 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018113592A Active JP6923486B2 (ja) | 2014-09-04 | 2018-06-14 | アナモレリンに基づく医療 |
| JP2021029775A Active JP7044918B2 (ja) | 2014-09-04 | 2021-02-26 | アナモレリンに基づく医療 |
Country Status (44)
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9492535B2 (en) | 2013-03-14 | 2016-11-15 | Aimmune Therapeutics, Inc. | Peanut formulations and uses thereof |
| HUE046894T2 (hu) | 2014-09-04 | 2020-04-28 | Helsinn Healthcare Sa | Anamorelinen alapuló gyógyászati kezelések |
| WO2020037151A1 (en) | 2018-08-16 | 2020-02-20 | Aimmune Therapeutics, Inc. | Peanut oral immunotherapy with maintenance dose |
| US12226448B2 (en) | 2018-12-20 | 2025-02-18 | Société des Produits Nestlé S.A. | Peanut oral immunotherapy dosing schedule for missed doses |
| US11229673B2 (en) | 2019-05-10 | 2022-01-25 | Société des Produits Nestlé S.A. | Methods for improving the quality of life of a patient with a peanut allergy |
| CN115569119A (zh) | 2019-08-30 | 2023-01-06 | 赫尔森保健股份公司 | 具有改善稳定性的阿拉莫林片剂的生产方法 |
| CA3158632A1 (en) | 2019-10-24 | 2021-04-29 | Toray Industries, Inc. | Therapeutic or prophylactic agent for cachexia |
| JP2024534464A (ja) * | 2021-09-17 | 2024-09-20 | 小野薬品工業株式会社 | 食欲不振／悪液質患者における患者報告アウトカムに関する臨床的に意味のある改善を判定し、提供する方法 |
| WO2025004650A1 (ja) * | 2023-06-28 | 2025-01-02 | 日清オイリオグループ株式会社 | 中高年者の疲労感を軽減するための剤及び組成物 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6303620B1 (en) | 1998-05-11 | 2001-10-16 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
| ECSP993020A (es) | 1999-06-16 | 1999-08-12 | Terapia de combinacion para la fragilidad musculoesqueletica | |
| ECSP993021A (es) | 1999-06-16 | 1999-08-12 | Combinaciones terapeuticas para la fragilidad musculoesqueletica | |
| US20010020012A1 (en) | 2000-02-01 | 2001-09-06 | Andersen Maibritt Bansholm | Use of compounds for the regulation of food intake |
| EP1660117A2 (en) * | 2003-08-06 | 2006-05-31 | Gastrotech Pharma A/S | Use of secretagogues like ghrelin in cancer cachexia and for stimulating appetite |
| CN1863550A (zh) * | 2003-08-06 | 2006-11-15 | 加斯特罗泰克药物公司 | 促分泌素样生长素释放肽在癌症恶病质中以及在刺激食欲方面的应用 |
| KR20070010151A (ko) | 2004-03-30 | 2007-01-22 | 사파이어 세라퓨틱스, 인크. | 성장 호르몬 분비촉진제를 이용하여 ｃ-반응성 단백질을감소시키는 방법 |
| EP1768976B1 (en) * | 2004-06-29 | 2017-04-26 | Helsinn Healthcare S.A. | Crystal forms of (3r)-1-(2-methylalanyl-d-tryptophyl)-3-(phenylmethyl)-3-piperidinecarboxylic acid 1,2,2-trimethylhydrazide |
| MX2009008561A (es) * | 2007-02-13 | 2010-01-15 | Helsinn Therapeutics Us Inc | Metodo para tratar trastornos proliferativos celulares utilizando secretagogos. |
| TWI429436B (zh) * | 2007-04-10 | 2014-03-11 | Helsinn Therapeutics Us Inc | 使用生長激素促泌素治療或預防嘔吐之方法 |
| JO3353B1 (ar) * | 2012-04-20 | 2019-03-13 | Ono Pharmaceutical Co | شكل صلب معزول من أحادي هيدروكلوريد أناموريلين بنسبة مولارية منخفضة من الكلوريد: أناموريلين ومحتوى منخفض من مذيب عضوي متبقي |
| CN104470524A (zh) * | 2012-05-25 | 2015-03-25 | 拉夸里亚创药株式会社 | 用于治疗胃酸缺乏症的生长激素释放肽受体激动剂 |
| HUE046894T2 (hu) | 2014-09-04 | 2020-04-28 | Helsinn Healthcare Sa | Anamorelinen alapuló gyógyászati kezelések |
-
2015
- 2015-08-28 HU HUE15838548A patent/HUE046894T2/hu unknown
- 2015-08-28 MD MDA20170025A patent/MD4710C1/ro active IP Right Grant
- 2015-08-28 BR BR112017003552A patent/BR112017003552A2/pt not_active Application Discontinuation
- 2015-08-28 PL PL15838548T patent/PL3188599T3/pl unknown
- 2015-08-28 MX MX2017002825A patent/MX361741B/es active IP Right Grant
- 2015-08-28 LT LT15838548T patent/LT3188599T/lt unknown
- 2015-08-28 HR HRP20192345TT patent/HRP20192345T1/hr unknown
- 2015-08-28 CR CR20170121A patent/CR20170121A/es unknown
- 2015-08-28 ES ES15838548T patent/ES2761777T3/es active Active
- 2015-08-28 PE PE2017000359A patent/PE20171109A1/es unknown
- 2015-08-28 MA MA40607A patent/MA40607B1/fr unknown
- 2015-08-28 CN CN202111026050.3A patent/CN113577073A/zh active Pending
- 2015-08-28 EP EP15838548.4A patent/EP3188599B1/en active Active
- 2015-08-28 ME MEP-2019-372A patent/ME03597B/me unknown
- 2015-08-28 DK DK15838548T patent/DK3188599T3/da active
- 2015-08-28 GE GEAP201514459A patent/GEP20186939B/en unknown
- 2015-08-28 UA UAA201702308A patent/UA120765C2/uk unknown
- 2015-08-28 EP EP19183144.5A patent/EP3590338A3/en not_active Withdrawn
- 2015-08-28 KR KR1020187020062A patent/KR102234319B1/ko active Active
- 2015-08-28 SG SG11201701567UA patent/SG11201701567UA/en unknown
- 2015-08-28 CA CA2959158A patent/CA2959158A1/en active Pending
- 2015-08-28 SI SI201530994T patent/SI3188599T1/sl unknown
- 2015-08-28 AU AU2015312231A patent/AU2015312231B2/en active Active
- 2015-08-28 PT PT158385484T patent/PT3188599T/pt unknown
- 2015-08-28 CN CN201580059744.3A patent/CN107205389A/zh active Pending
- 2015-08-28 EA EA201790352A patent/EA035578B1/ru unknown
- 2015-08-28 CN CN202111027023.8A patent/CN113577074A/zh active Pending
- 2015-08-28 US US14/839,038 patent/US9675600B2/en active Active
- 2015-08-28 TN TN2017000040A patent/TN2017000040A1/en unknown
- 2015-08-28 KR KR1020177008748A patent/KR101881264B1/ko active Active
- 2015-08-28 KR KR1020217008765A patent/KR102307275B1/ko active Active
- 2015-08-28 CN CN201710646685.0A patent/CN107375285A/zh active Pending
- 2015-08-28 MY MYPI2017700714A patent/MY187167A/en unknown
- 2015-08-28 RS RS20191688A patent/RS59751B1/sr unknown
- 2015-08-28 WO PCT/US2015/047435 patent/WO2016036598A1/en not_active Ceased
- 2015-08-28 CN CN201811119404.7A patent/CN109172575A/zh active Pending
- 2015-08-28 JP JP2017512679A patent/JP6356907B2/ja active Active
- 2015-08-28 AP AP2017009772A patent/AP2017009772A0/en unknown
- 2015-08-30 JO JOP/2015/0210A patent/JO3541B1/ar active
- 2015-09-01 TW TW104128838A patent/TWI639429B/zh active
- 2015-09-02 UY UY0001036286A patent/UY36286A/es not_active Application Discontinuation
- 2015-09-03 AR ARP150102818A patent/AR103118A1/es unknown
-
2017
- 2017-02-20 IL IL250692A patent/IL250692B/en active IP Right Grant
- 2017-03-02 CL CL2017000494A patent/CL2017000494A1/es unknown
- 2017-03-02 PH PH12017500392A patent/PH12017500392B1/en unknown
- 2017-03-03 DO DO2017000055A patent/DOP2017000055A/es unknown
- 2017-03-03 NI NI201700024A patent/NI201700024A/es unknown
- 2017-03-03 SV SV2017005400A patent/SV2017005400A/es unknown
- 2017-03-30 EC ECIEPI201719893A patent/ECSP17019893A/es unknown
- 2017-04-03 CO CONC2017/0003263A patent/CO2017003263A2/es unknown
- 2017-05-09 US US15/590,025 patent/US10278964B2/en active Active
-
2018
- 2018-06-14 JP JP2018113592A patent/JP6923486B2/ja active Active
-
2019
- 2019-02-14 US US16/275,669 patent/US10894041B2/en active Active
- 2019-12-16 CY CY20191101321T patent/CY1122746T1/el unknown
-
2020
- 2020-12-11 US US17/119,482 patent/US11723902B2/en active Active
-
2021
- 2021-02-26 JP JP2021029775A patent/JP7044918B2/ja active Active
-
2023
- 2023-06-22 US US18/212,720 patent/US20240024303A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017526695A5 (cg-RX-API-DMAC7.html) | ||
| JP2019503365A5 (cg-RX-API-DMAC7.html) | ||
| EA201170018A1 (ru) | Разагилин для изменения течения болезни паркинсона | |
| FI3849534T3 (fi) | Yhdistelmähoidot | |
| FI3504187T3 (fi) | Pridopidiinin käyttö toiminnallisen heikkenemisen hoitoa varten | |
| EP4631944A3 (en) | Rimegepant for cgrp related disorders | |
| MX2021002322A (es) | Nuevos metodos. | |
| JP2016528162A5 (cg-RX-API-DMAC7.html) | ||
| PH12014502447A1 (en) | Use of high dose laquinimod for treating multiple sclerosis | |
| HK1221646A1 (zh) | 高剂量普利多匹定用於治疗亨廷顿舞蹈症的用途 | |
| JP2015505564A5 (cg-RX-API-DMAC7.html) | ||
| HRP20250615T1 (hr) | Tradipitant za upotrebu u liječenju gastropareze | |
| JP2016147915A5 (cg-RX-API-DMAC7.html) | ||
| JP2016512817A5 (cg-RX-API-DMAC7.html) | ||
| HK1202776A1 (en) | Use of laquinimod for treating crohn's disease patients who failed first-line anti-tnf therapy | |
| JP2015532296A5 (cg-RX-API-DMAC7.html) | ||
| JO3434B1 (ar) | مركبات صيدلانية لمعالجة السرطان وامراض واضطرابات اخري | |
| JP2018090566A5 (cg-RX-API-DMAC7.html) | ||
| HRP20192345T1 (hr) | Medicinski tretmani na bazi anamorelina | |
| JP2014508758A5 (cg-RX-API-DMAC7.html) | ||
| PH12020551911A1 (en) | Use of riluzole oral disintigrating tablets for treating diseases | |
| NZ700924A (en) | Dosage regimen for a pi-3 kinase inhibitor | |
| MX2021001563A (es) | Uso de tabletas de desintegracion oral de riluzol para tratar enfermedades. | |
| JP2017526693A5 (cg-RX-API-DMAC7.html) | ||
| JP2016505050A5 (cg-RX-API-DMAC7.html) |